YAMAHA INTEGRATED REPORT 2018
28/90

Accelerating Innovation through PartnershipsNVIDIA (U.S.); DMP (Japan)Robotics segment (1)Advances in automation through AI, including unmanned agricultural vehicles and dronesSeeing AI as the core of control technologies going forward, we are working to accelerate innovation through partnerships. We are collaborating with NVIDIA, a leading AI computing company, to add intelligent technology to robot products. This collaboration will involve the use of image processing technologies using GPUs (graphics processing units) and the development environment to support our upstream development of AI technologies. We have also entered into a business capital tie-up agreement with AI computing specialist Digital Media Professionals Inc. (DMP). By incorporating DMP’s deep-learning, image processing, and image recognition technologies into our products and technologies, we intend to expand the possibilities for the creation of new value using low-speed automatic/autonomous driving systems, robot utilization in agricultural applications, and advanced safety technologies in various areas of mobility. Hubrecht Organoid Technology (the Netherlands)Robotics segment (2)Accelerating technological development in the biomedical engineering fieldYamaha Motor is conducting joint research with Hubrecht Organoid Technology (HUB) to accelerate its research and development into organoids, which are patient-derived cell cultures that mimic human organ function.HUB is one of the world’s leading research centers in the field of organoids, and was established in 2013 by the Hubrecht Institute, the Royal Netherlands Academy of Arts and Sciences, and University Medical Center Utrecht. Using organoid technology and working with academic institutions and pharmaceutical companies, HUB is promoting medical research, drug development, and personalized medicine in areas including cancer and cystic fibrosis. Through this joint research, Yamaha Motor will strengthen its cell-picking and image-processing technologies, which are the core features of the CELL HANDLERTM cell-handling device, and contribute to advances in organoid research, thereby promoting medical research and new drug development.From the PresidentYamaha Motor Co., Ltd. Integrated Report 201826

元のページ  ../index.html#28

このブックを見る